S. An

发表

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

B. Qian, Hongbing Shen, Chien-Jen Chen, 2012, Nature Genetics.

The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer

Jian Su, Jia-Ying Lin, Yi-long Wu, 2009, BMC Cancer.

Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2012, Medical Oncology.

KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer

T. Mok, Yi-long Wu, Rong Li, 2007, Journal of Cancer Research and Clinical Oncology.

Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polymorphism of Rs9387478 Correlates with Overall Survival in Female Nonsmoking Patients with Lung Cancer

N. Rothman, Yi-long Wu, Jin-Ji Yang, 2016, The International journal of biological markers.

In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines

Yi-long Wu, S. An, Xuchao Zhang, 2011, Cancer Chemotherapy and Pharmacology.

Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.

Y. Wu, S. An, Xuchao Zhang, 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer.

Yi-long Wu, S. An, Xuchao Zhang, 2012, Experimental and therapeutic medicine.

The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib.

T. Mok, Yi-long Wu, S. An, 2007, European journal of pharmacology.

Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer

Yi-long Wu, W. Zhong, S. An, 2018, Journal of Cancer.

MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation

Yi-long Wu, S. An, Jian Su, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Three cases of severe hepatic impairment caused by erlotinib.

Yi-long Wu, S. An, Zhi-hong Chen, 2009, British journal of clinical pharmacology.

[High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer].

Yilong Wu, S. An, Xuchao Zhang, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancer.

Yi-long Wu, Chongrui Xu, S. An, 2013, Cancer biomarkers : section A of Disease markers.

A dendritic cell‐based tumour vaccine for lung cancer: full‐length XAGE‐1b protein‐pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro

Y. Wu, S. An, Q. Zhou, 2008, Clinical and experimental immunology.

Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.

T. Mok, Yi-long Wu, S. An, 2008, Human pathology.

An Autologous Therapeutic Dendritic Cell Vaccine Transfected with Total Lung Carcinoma RNA Stimulates Cytotoxic T Lymphocyte Responses Against Non-Small Cell Lung Cancer

Yi-long Wu, Chongrui Xu, S. An, 2009, Immunological investigations.

miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer

R. Brem, S. Tabbara, Y. Man, 2014, Breast Cancer Research.

Deregulated miRNAs in Triple Negative Breast Cancer

S. An, S. Fu, Xiaohui Tan, 2016 .

MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma

Zuo-ren Wang, S. An, S. Fu, 2014, Journal of Cancer.

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2010, Molecular Cancer.

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women.

X. Hua, Jianxin Shi, Y. Miyagi, 2019, Genomics.

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Ping Wang, Junjie Wu, Jian Su, 2016, Human molecular genetics.

Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.

Hongbing Shen, Chien-Jen Chen, N. Rothman, 2016, Human molecular genetics.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

Jian Su, Wen Tan, Paolo Vineis, 2015, Journal of the National Cancer Institute.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Alison P. Klein, William Wheeler, Li Jin, 2015 .

CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2011, European Journal of Cancer.

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals.

T. Mok, Yi-long Wu, W. Zhong, 2008, Cancer letters.

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

Yi-long Wu, S. An, Xuchao Zhang, 2016, PloS one.

KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2013, Annals of Surgical Oncology.

Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

T. Mok, Yi-long Wu, Jin-Ji Yang, 2012, PloS one.

EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

T. Mok, Yi-long Wu, Jin-Ji Yang, 2012, The oncologist.

Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib

Yi-long Wu, S. An, Xuchao Zhang, 2011, Journal of hematology & oncology.

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer consortium in Asia

B. Qian, Hongbing Shen, Chien-Jen Chen, 2015, International journal of cancer.

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay

Yi-long Wu, W. Zhong, S. An, 2014, Chinese journal of cancer.

[Analysis of Differentially Expressed Proteins in Self-Paired Sera of Advanced Non-small Cell Lung Cancer Patients Responsive to Gefinitib.].

Jin-Ji Yang, Xue-Ning Yang, Yilong Wu, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Lung cancer treatment disparities in China: a question in need of an answer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2014, The oncologist.

Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC).

Yi-long Wu, Xue-Ning Yang, S. An, 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Elevated expression level of laminin 5 may be a negative predictive factor for the response to gefitinib in lung cancer patients

Yi-long Wu, S. An, Jian-quan Zhu, 2008 .

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

L. Kiemeney, Y. Miyagi, B. Qian, 2023, Nature communications.

Open Access Research

Jianfeng Xu, Jin-Ji Yang, S. Cramer, 2022 .

Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapy

S. An, Zhi-hong Chen, Qing Zhou, 2014, Cancer Gene Therapy.

Abstract 3062: miR-671-5p promotes epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer

R. Brem, S. Tabbara, Y. Man, 2015 .

Open Access RESEARCH

Young Yang, Peter Suber, Yi-long Wu, 2010 .

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals.

T. Mok, Yi-long Wu, W. Zhong, 2008, Cancer letters.

MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation

Yi-long Wu, S. An, Zhi-hong Chen, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Mutation and polymorphism in the tyrosine kinase domain of KDR in Chinese human lung cancer patients

Yi-long Wu, S. An, Zhi-hong Chen, 2009 .